Thymogen manufacturer

Cytomed is a specialized pharmaceutical company focused on the research, development, and production of peptide-based therapeutic agents. Founded in 1989 in St. Petersburg, Russia, the company is the original developer and manufacturer of Thymogen, a synthetic dipeptide immunomodulator used to treat various immune-related conditions. Cytomed operates state-of-the-art manufacturing facilities in both Russia and Finland, ensuring compliance with international Good Manufacturing Practice (GMP) standards. The company's product portfolio extends beyond immunology to include treatments for urology, pediatrics, and dermatology. By leveraging its expertise in peptide synthesis, Cytomed continues to innovate in the field of bioregulation and physiological restoration.